Investigating the frequency of patients with records of clinical attacks (onset or relapses) reported within 3 months following infection or vaccination, we observed no significant difference between the isolated MOG-IgA (7/11 [64%]) and MOG-IgG (7/19 [37%]) groups. The gene discussed is CD79A; the disease is infection.